1 unknown, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
Follow UB-421: new trials by email Literature Review of UB-421 trials Research Report on UB-421
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults UB-421, current standard HAART treatment - HIV-1 Infection | Phase 3 | Withdrawn | United BioPharma | 2025-04-01 | 2023-04-25 | |
| UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection UB-421, Antiretroviral (ARV) - HIV-1 Infection | Phase 3 | Unknown | United BioPharma | 50 | 2023-12-01 | 2023-04-24 |
United BioPharma (2)
China (1)